Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Allergies
Sort By
Newest First
Sign in
1 / 1
1 / 1
Immunology
Applying Revolutionary Thinking to Autoimmune and Allergic Diseases
Jonathan Rigby
Revolo Biotherapeutics
PAO-04-22-R250-66
Apr 19, 2022
Rebranding
Immune Regulation Announces Rebranding to Revolo Biotherapeutics, Reflecting a Revolutionary Approach to Resetting the Immune System to Treat Autoimmune and Allergic Diseases
Revolo Biotherapeutics
PR-M11-20-041
Mar 05, 2021
Allergies
Developing a Microbiome-Based Treatment for Food Allergies
John Colson, Ph.D.
ClostraBio
PAP-Q3-19-CL-008
Oct 28, 2019
Drug Pricing
Pricing Concerns Already Raised About Development Treatments for Peanut Allergies
Nice Insight
PAO-M08-19-NI-003
Aug 01, 2019
FDA Statement
Statement from FDA Commissioner Scott Gottlieb, M.D., on the FDA's new consideration of labeling for sesame allergies
U.S. Food & Drug Administration
PR-M10-18-NI-109
Oct 31, 2018
FDA Approval
FDA Grants Breakthrough Therapy Designation for Xolair(Omalizumab) for Food Allergies
Genentech
PR-M09-18-NI-005
Sep 04, 2018
